![]() |
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
|
Home
/ Technology News / 2008 / January 2008 / January 28, 2008 Needle-free pain treatment introduced |
Stem cell heart surgery may spell the end for transplantation
British scientists have developed a new technique that can rebuild a severely damaged heart, and one day, might replace the need for transplantation. ANI
A new insight into the turbulent atmosphere of Venus
New images taken by instruments on board ESAs (European Space Agencys) Venus Express have provided insight into the turbulent atmosphere of our neighbouring planet. ANI
ESA tests laser to measure atmospheric CO2
A recent ESA (European Space Agency) campaign has demonstrated how a technique using lasers could be employed to measure carbon dioxide (CO2) in the atmosphere. ANI
Getting rid of pain following an operation will no longer be a torturous affair, for a new needle-free method of relieving acute pain has been introduced in markets of Germany, Britain and Ireland.
Melbourne, Jan 28 : Getting rid of pain following an operation will no longer be a torturous affair, for a new needle-free method of relieving acute pain has been introduced in markets of Germany, Britain and Ireland.
The fentanyl iontophoretic transdermal system (IONSYS) will replace needles, pumps, catheters or intravenous pump stands, reducing the risk of needle-stick injuries and infection.
The product is being marketed by Janssen- Cilag International NV, and it claims that this method has the ability to make the administration of post- operative pain management a less time-consuming job for healthcare professionals and less intrusive for patients.
With the size of a credit card, it is strapped to a patient's upper outer arm or chest, reports theage.com.au.
By using a nearly imperceptible low-intensity electrical field to rapidly transport doses of fentanyl, a pain-killer, through the skin and into the bloodstream.
Also, it reduces the potential for abuse, as it automatically shuts down after the maximum number of doses has been administered.
The marketing authorisation for IONSYS was given by the European Commission, after clinical trials showed that it is as effective as intravenous PCA morphine for the management of acute post-operative pain.
ANI